Durata Therapeutics
Durata Therapeutics was a clinical-stage pharmaceutical company founded in 2009 around anti-infective assets acquired from Pfizer's Vicuron division, headquartered first in Morristown, New Jersey and from 2012 in Chicago, Illinois. Its lead candidate was dalbavancin, a long-acting semisynthetic lipoglycopeptide antibiotic taken into Phase III trials from 2011 for acute bacterial skin and skin-structure infections and later marketed as Dalvance. The company was backed by Canaan Partners and was acquired by Actavis (now Allergan) on November 17, 2014 for approximately $675 million, at which point it ceased to operate as an independent entity. Durata Therapeutics published no developer program, no public API, and no machine-readable API artifacts; its corporate domain duratatherapeutics.com no longer resolves. This profile is retained as a historical company record in the API Evangelist network.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Durata Therapeutics is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Durata Therapeutics scores 5.7/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
Durata Therapeutics is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/durata-therapeutics · machine-readable index on apis.io